HK Stock Market Move | Guolian Minsheng (01456) rises more than 5% after performance, with a 32.07% year-on-year increase in net profit attributable to the mother in the first quarter.
Guolian Lifesciences (01456) surged over 5% after its performance announcement. As of press time, it rose 5.86% to HKD 4.7, with a turnover of HKD 10.9024 million.
Guolian Minsheng (01456) rose more than 5% after its performance, with a gain of 5.86% as of press time, closing at HK$4.7, with a trading volume of HK$10.90 million.
On the news front, on April 27th, Guolian Minsheng released its first-quarter performance for 2026, with operating income of HK$1.856 billion, an increase of 18.81% year-on-year; net profit attributable to shareholders of the listed company was HK$497 million, an increase of 32.07% year-on-year; and basic earnings per share was HK$0.09.
Related Articles
J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.
UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.
LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.
J&T EXPRESS-W (01519) spent 23.4103 million Hong Kong dollars to repurchase 2.284 million shares on April 28th.
UNITED LAB (03933): TUL321 Capsules receive approval for new drug clinical trials by the US FDA.
LEGENDHOLDING (03396) will distribute a final dividend of 0.1 yuan per share on August 28th.
